Hey there! Welcome!
Get updated on
Select Speciality
Top Picks
Key session presented at the European Respiratory Society (ERS) International Congress 2023, Milan, Italy, 9-13 September
30 Jun, 23
Warfarin is a drug used to prevent harmful blood clots following is the guide on precautions & diet to be followed while a patient is on warfarin therapy
A retrospective cohort study in Africa found that risk of developing clinical malaria among people with undetected sub-patent infections is low. A slightly elevated risk in low season whereas the opposite was true in the high transmission season.
Diabetes (DM) patients have inherently higher risk of CV outcomes & bleeding irrespective of aspirin dosing, warned a recent study. Patients with versus vs. without DM had higher rates of the CV outcome (9.6% vs. 5.9%) & bleeding events (0.78% vs. 0.50%); use of 81 mg vs. 325 mg of aspirin, in DM patients did not impact these outcomes. A higher aspirin dose may yield no added benefit in more vulnerable DM patients.
- First-line options for OAB include antimuscarinics, β-3 agonists and posterior tibial nerve stimulation and second-line options include onabot-A injections or sacral nerve stimulation
- β-3 agonists were more effective at reducing nocturia episodes than antimuscarinics
- SNS had higher success rate than antimuscarinics; 61% vs 42%
- Rate of recurrent UTIs was higher with onabot-A than SNS; 24% vs 10%
- In pediatric IHCA, medical cardiac group had lower odds of survival with favorable neurologic outcomes vs. noncardiac group (48% vs 55%; aOR 0.59, p=0.008) & surgical cardiac group (48% vs 58%; aOR 0.64, p=0.01)
- Surgical cardiac group had lower odds of achieving target chest compressions (CC) depth vs. noncardiac group (OR 0.15)
- No difference seen in CC rate/fraction, ventilation rate, intra-arrest target BP
Featured

19 Apr, 23

24 Apr, 23

13 Jan, 22